Online inquiry

IVTScrip™ mRNA-Human ANKRD44, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17926MR)

This product GTTS-WK17926MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD44 protein. This product can be used in Lymphoid-primed multipotent progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001195144.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 91526
UniProt ID Q8N8A2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD44, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17926MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK25962MR IVTScrip™ mRNA-Human ARNT2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARNT2
GTTS-WK24990MR IVTScrip™ mRNA-Human ARHGAP25, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP25
GTTS-WK14968MR IVTScrip™ mRNA-Human AOAH, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AOAH
GTTS-WK23164MR IVTScrip™ mRNA-Human ARF3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARF3
GTTS-WK28243MR IVTScrip™ mRNA-Human APPL1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA APPL1
GTTS-WK10092MR IVTScrip™ mRNA-Human ADAM19, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADAM19
GTTS-WK15300MR IVTScrip™ mRNA-Human APBB2, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA APBB2
GTTS-WK4367MR IVTScrip™ mRNA-Human TNC, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA TNC
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →